1. 1) Fujita T, Uchida K, Maruyama N. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim. Biophys. Acta, 1116, 122–128 (1992).
2. 2) Ishigami A, Maruyama N. Significance of SMP30 in gerontology. Geriatr. Gerontol. Int., 7, 316–325 (2007).
3. 3) Mori T, Ishigami A, Seyama K, Onai R, Kubo S, Shimizu K, Maruyama N, Fukuchi Y. Senescence marker protein-30 knockout mouse as a novel murine model of senile lung. Pathol. Int., 54, 167–173 (2004).
4. 4) Ishigami A, Fujita T, Handa S, Shirasawa T, Koseki H, Kitamura T, Enomoto N, Sato N, Shimosawa T, Maruyama N. Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-α- and Fas-mediated apoptosis. Am. J. Pathol., 161, 1273–1281 (2002).
5. 5) Ishigami A, Kondo Y, Nanba R, Ohsawa T, Handa S, Kubo S, Akita M, Maruyama N. SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem. Biophys. Res. Commun., 315, 575–580 (2004).